{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:01:49Z","timestamp":1758585709351,"version":"3.44.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,21]]},"DOI":"10.7759\/cureus.92865","type":"journal-article","created":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T18:19:48Z","timestamp":1758478788000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparative Effectiveness of Lifestyle Versus Pharmacologic Therapy in Non-alcoholic Fatty Liver Disease (NAFLD): A 12-Month Multicenter Observational Study"],"prefix":"10.7759","author":[{"given":"Zubair","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Hamza","family":"Ghufran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suleman","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeeshan","family":"Muzaffar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qazi","family":"Muhammad Safwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Nouman","family":"Shuja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamza","family":"Usman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usman","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Ali Abdullah","family":"Jan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naqeeb","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5114\/aoms\/150639","article-title":"Non-alcoholic fatty liver disease, metabolic syndrome, and type 2 diabetes mellitus: where do we stand today?","volume":"19","author":"Mitrovic B","year":"2023","unstructured":"Mitrovic B, Gluvic ZM, Obradovic M, Radunovic M, Rizzo M, Banach M, Isenovic ER. Non-alcoholic fatty liver disease, metabolic syndrome, and type 2 diabetes mellitus: where do we stand today?. Arch Med Sci. 2023, 19:884-94. 10.5114\/aoms\/150639","journal-title":"Arch Med Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00003-1","article-title":"A global view of the interplay between non-alcoholic fatty liver disease and diabetes","volume":"10","author":"Stefan N","year":"2022","unstructured":"Stefan N, Cusi K. A global view of the interplay between non-alcoholic fatty liver disease and diabetes. Lancet Diabetes Endocrinol. 2022, 10:284-96. 10.1016\/S2213-8587(22)00003-1","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvad095","article-title":"Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options","volume":"119","author":"Grander C","year":"2023","unstructured":"Grander C, Grabherr F, Tilg H. Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options. Cardiovasc Res. 2023, 119:1787-98. 10.1093\/cvr\/cvad095","journal-title":"Cardiovasc Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/imj.14709","article-title":"Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management","volume":"50","author":"Huang TD","year":"2020","unstructured":"Huang TD, Behary J, Zekry A. Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management. Intern Med J. 2020, 50:1038-47. 10.1111\/imj.14709","journal-title":"Intern Med J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2018.03.016","article-title":"Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors","volume":"12","author":"Al-Dayyat HM","year":"2018","unstructured":"Al-Dayyat HM, Rayyan YM, Tayyem RF. Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors. Diabetes Metab Syndr. 2018, 12:569-75. 10.1016\/j.dsx.2018.03.016","journal-title":"Diabetes Metab Syndr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i26.8341","article-title":"Modern approach to the clinical management of non-alcoholic fatty liver disease","volume":"20","author":"Del Ben M","year":"2014","unstructured":"Del Ben M, Polimeni L, Baratta F, Pastori D, Loffredo L, Angelico F. Modern approach to the clinical management of non-alcoholic fatty liver disease. World J Gastroenterol. 2014, 20:8341-50. 10.3748\/wjg.v20.i26.8341","journal-title":"World J Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3904\/kjm.2014.86.4.416","article-title":"Nonalcoholic fatty liver disease: lifestyle modification","volume":"86","author":"Yoo KD","year":"2014","unstructured":"Yoo KD, Jun DW. Nonalcoholic fatty liver disease: lifestyle modification. Korean J Med. 2014, 86:416-24. 10.3904\/kjm.2014.86.4.416","journal-title":"Korean J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2023.2172397","article-title":"Comparative efficacy of glucagon-like peptide 1 (GLP-1) receptor agonists, pioglitazone and vitamin E for liver histology among patients with nonalcoholic fatty liver disease: systematic review and pilot network meta-analysis of randomized controlled trials","volume":"17","author":"Gu Y","year":"2023","unstructured":"Gu Y, Sun L, He Y, et al.. Comparative efficacy of glucagon-like peptide 1 (GLP-1) receptor agonists, pioglitazone and vitamin E for liver histology among patients with nonalcoholic fatty liver disease: systematic review and pilot network meta-analysis of randomized controlled trials. Expert Rev Gastroenterol Hepatol. 2023, 17:273-82. 10.1080\/17474124.2023.2172397","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/20503121241227090","article-title":"Effect of exercise and pharmacotherapy on non-alcoholic fatty liver disease","volume":"12","author":"Kandel A","year":"2024","unstructured":"Kandel A, Pant P, Todi S, Kc S, Pandey S. Effect of exercise and pharmacotherapy on non-alcoholic fatty liver disease. SAGE Open Med. 2024, 12:20503121241227090. 10.1177\/20503121241227090","journal-title":"SAGE Open Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052350","article-title":"Treatments for NAFLD: state of art","volume":"22","author":"Mantovani A","year":"2021","unstructured":"Mantovani A, Dalbeni A. Treatments for NAFLD: state of art. Int J Mol Sci. 2021, 22:2350. 10.3390\/ijms22052350","journal-title":"Int J Mol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez E","year":"2015","unstructured":"Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al.. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015, 149:367-78.e5; quiz e14-5. 10.1053\/j.gastro.2015.04.005","journal-title":"Gastroenterology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20251","article-title":"Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss","volume":"39","author":"Dixon JB","year":"2004","unstructured":"Dixon JB, Bhathal PS, Hughes NR, O'Brien PE. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology. 2004, 39:1647-54. 10.1002\/hep.20251","journal-title":"Hepatology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2005.042200","article-title":"Treatment of non-alcoholic fatty liver disease","volume":"82","author":"Adams LA","year":"2006","unstructured":"Adams LA, Angulo P. Treatment of non-alcoholic fatty liver disease. Postgrad Med J. 2006, 82:315-22. 10.1136\/pgmj.2005.042200","journal-title":"Postgrad Med J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22009","article-title":"Behavior therapy for nonalcoholic fatty liver disease: the need for a multidisciplinary approach","volume":"47","author":"Bellentani S","year":"2008","unstructured":"Bellentani S, Dalle Grave R, Suppini A, Marchesini G. Behavior therapy for nonalcoholic fatty liver disease: the need for a multidisciplinary approach. Hepatology. 2008, 47:746-54. 10.1002\/hep.22009","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4747","article-title":"Management of non-alcoholic fatty liver disease","volume":"372","author":"Petroni ML","year":"2021","unstructured":"Petroni ML, Brodosi L, Bugianesi E, Marchesini G. Management of non-alcoholic fatty liver disease. BMJ. 2021, 372:m4747. 10.1136\/bmj.m4747","journal-title":"BMJ"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/405195-comparative-effectiveness-of-lifestyle-versus-pharmacologic-therapy-in-non-alcoholic-fatty-liver-disease-nafld-a-12-month-multicenter-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T18:19:49Z","timestamp":1758478789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/405195-comparative-effectiveness-of-lifestyle-versus-pharmacologic-therapy-in-non-alcoholic-fatty-liver-disease-nafld-a-12-month-multicenter-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,21]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.92865","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,21]]}}}